Follow the 알리코제약 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 알리코제약 has logged 23 insider filings. The latest transaction was disclosed on 4 June 2026 (Other). Among the most active insiders: 이항구. Every trade is openly available.
22
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
13 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Allico Pharmaceutical is a company operating in the health and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and marketing of pharmaceutical products.